H. Earl Ruley
- Molecular Biology top 0.5%
- Oncology top 0.5%
- Genetics top 0.5%
- Cancer Research top 1%
- Biotechnology top 0.2%
- Co-authors
- Tyler JacksScott W. LoweDavid E. HousmanS. W. LoweAndrea I. McClatcheyDavid E. FisherStephan BodisLee Ann Remington
- Topics
- Virus-based gene therapy research (24 papers)CRISPR and Genetic Engineering (15 papers)Cancer-related Molecular Pathways (10 papers)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
H. Earl Ruley
74 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Molecular Biology 6.3k
- Oncology 4.5k
- Genetics 2.4k
- Cancer Research 1.1k
- Biotechnology 1.1k
Countries citing papers authored by H. Earl Ruley
This map shows the geographic impact of H. Earl Ruley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Earl Ruley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Earl Ruley more than expected).
Fields of papers citing papers by H. Earl Ruley
This network shows the impact of papers produced by H. Earl Ruley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Earl Ruley. The network helps show where H. Earl Ruley may publish in the future.
Co-authorship network of co-authors of H. Earl Ruley
This figure shows the co-authorship network connecting the top 25 collaborators of H. Earl Ruley. A scholar is included among the top collaborators of H. Earl Ruley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Earl Ruley. H. Earl Ruley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 13 | |
| 3 | 13 | |
| 4 | 31 | |
| 5 | 10 | |
| 6 | 14 | |
| 7 | 15 | |
| 8 | 15 | |
| 9 | 11 | |
| 10 | 55 | |
| 11 | 14 | |
| 12 | 2 | |
| 13 | 54 | |
| 14 | 231 | |
| 15 | 12 | |
| 16 | 97 | |
| 17 | 32 | |
| 18 | 34 | |
| 19 | 6 | |
| 20 | 1 |
About H. Earl Ruley
H. Earl Ruley is a scholar working on Genetics, Biotechnology and Molecular Biology, having authored 74 papers that have together received 10.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (24 papers), CRISPR and Genetic Engineering (15 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Oncology (4.5k citations), Biotechnology (1.1k citations) and Molecular Biology (6.3k citations). H. Earl Ruley has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Tyler Jacks, Scott W. Lowe, David E. Housman, S. W. Lowe, Andrea I. McClatchey, David E. Fisher, Stephan Bodis, Lee Ann Remington, Jin Chen and Geoffrey G. Hicks. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.